In this study, we sought to comprehensively investigate the transcriptomic and clinical significance of LGALS3 expression in cancer, with a particular focus on pancreatic ductal adenocarcinoma (PDAC). This evidence concerns the gene LGALS3 and pancreatic ductal adenocarcinoma.